Hi there! ππ½
A screener is an easy method to eliminate 95% of stocks out there.
Most stocks are not worth researching. To save time, we can utilize screeners and get a set of quality businesses to dive deeper into.
In case you missed it:
Eliminate 95% of companies by putting it through this filter
ROIC +15%
Revenue Growth 5Y +10%
Free cash flow growth 5Y +10%
Interest coverage +10x
Gross margin +40%
Operating margin +10%
Shares outstanding <2%
We use the stock screener from Stockopedia to extract this data:
40 examples
These 40 businesses meet the criteria and are sorted by market capitalization.
5 Businesses with high sales growth π
Genmab A/S
Based in Denmark, Genmab is a leading biotechnology company focusing on the development of differentiated antibody therapeutics for the treatment of cancer, autoimmune, infectious, and central nervous system diseases.
Utilizing cutting-edge technology platforms such as DuoBody and HexaBody, they aim to create innovative and effective treatments.
Key fundamentals:
DKK 115.52B
Gross Margin +97.69%
Operating Margin +32.08%
ROIC 5-year +79.48%
Interest coverage 203.74x
Revenue growth 5-year +43.38%
EPS growth 5-year +30.73%
Smartcraft ASA
A Norwegian technology firm, Smartcraft provides specialized software solutions to enhance productivity and management in the construction and crafts industries.
Their products support various business functions, including project management and financials, aiming to streamline operations and improve efficiencies.
Key fundamentals:
Market capitalization NOK 4.967M
Gross Margin +56%
Operating Margin +32.04%
ROIC 5-year +8.9%
Interest coverage 652x
Revenue growth 5-year +39.9%
EPS growth 5-year +33.76%
cBrain A/S
cBrain, a Danish software company, offers digital solutions to transform public administration processes.
Their key product, the F2 suite, helps government agencies manage digital workflows, enhancing transparency and efficiency. This supports a shift towards a more digital, paperless government.
Key fundamentals:
Market capitalization DKK 4.861M
Gross Margin +59.47%
Operating Margin +35.71%
ROIC 5-year +16.59%
Interest coverage 18.77x
Revenue growth 5-year +23.43%
EPS growth 5-year +90.8%
Neurocrine Biosciences
Neurocrine Biosciences is focused on developing treatments for neurological and endocrine-related disorders, including Parkinson's disease and endometriosis.
They are known for their development of Ingrezza, a leading treatment for tardive dyskinesia, showcasing their commitment to addressing unmet medical needs.
Key fundamentals:
Market capitalization: $13.63B
Gross Margin +68.54%
Operating Margin +23.73%
ROIC 5-year +50.33%
Interest coverage 102.26x
Revenue growth 5-year +30.76%
EPS growth 5-year +52.77%
CD Projekt SA
CD Projekt is a prominent Polish video game developer and publisher. CD is known for its rich narrative-driven games such as the Witcher series and Cyberpunk 2077.
Their commitment to high-quality game design and storytelling has established them as a leader in the video game industry, with a strong focus on user experience and expansive open-world environments.
Key fundamentals:
Market capitalization: PLN 14.3B
Gross Margin +69.61%
Operating Margin +37.4%
ROIC 5-year +39.25%
Interest coverage 455.42x
Revenue growth 5-year +28.33%
EPS growth 5-year +37.48%
Whenever you are ready, this is how I can help you:
Go Premium to access exclusive content & follow our market-beating Quality Growth portfolio. Read more here.
Essentials of Quality Growth β Join more than 250 investors who have bought the guide. Essentials of Quality Growth Investing is a multi-step guide for building a stock market portfolio of 10-20 high-performing quality compounders.
(Free) Valuation Cheat Sheet β Learn an easy and reliable method of valuing a business. Learn how to set a margin of safety for your investments.
(Free) How to identify a compounder β Learn how to effectively look for great companies that you can buy and hold for the long term.
(Free) How to analyze the financial statements β Learn how you read & analyze the balance sheet, income statement, and cash flow statement.
Promote yourself to +8.000 stock market investors (48% open rate) β Contact us via: investinassets20@gmail.com
Great article, but one thing not clear: Shares outstanding <2%
I believe you meant to say Shares Dilution <2% ?
Canβt have stock price growth without internal growthβ¦